BCAA and L-Alanine Composition for Muscle Wasting Absorption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing treatments and supplements fail to effectively prevent or treat muscle wasting associated with pathological and age-related conditions, such as muscular dystrophy, cancer-associated cachexia, and sarcopenia, by not adequately maintaining muscle mass and function.
Innovation Solution
A composition comprising branched-chain amino acids (BCAAs) and L-Alanine, in specific weight ratios, is administered to enhance muscle protein synthesis and absorption, thereby preventing or treating muscle wasting.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If BCAAs are administered alone, then muscle protein synthesis is stimulated, but absorption and utilization are insufficient to effectively prevent muscle wasting
Solution Approach 1:
The patent combines BCAAs with L-Alanine in a specific composition to enhance the absorption and utilization of BCAAs. The synergistic effect of combining these amino acids addresses the insufficiency of BCAA absorption when administered alone, thereby improving reliability in preventing muscle wasting.
Solution Approach 2:
The invention creates a composite amino acid formulation combining BCAAs (Leucine, Valine, Isoleucine) with L-Alanine in specific weight ratios. This composite composition leverages the complementary properties of different amino acids to achieve superior absorption and anti-catabolic effects compared to individual amino acid supplements.
2Reliability
If existing treatments are used, then muscle wasting conditions are addressed, but muscle mass and function are not adequately maintained
Solution Approach 1:
The patent optimizes the weight ratios of amino acids in the composition (BCAAs:Leucine 2-8 parts, Valine 1-3 parts, Isoleucine 1-3 parts, L-Alanine 1-2 parts) to achieve optimal absorption and utilization. This parameter optimization ensures both maintenance of muscle mass and preservation of muscle function in wasting conditions.
Solution Approach 2:
L-Alanine acts as an intermediary that enhances the absorption and utilization of BCAAs in the composition. The presence of L-Alanine facilitates better uptake and metabolic utilization of the branched-chain amino acids, thereby improving both muscle mass maintenance and functional outcomes.
3Productivity
If BCAA supplementation is increased, then muscle protein synthesis is enhanced, but absorption efficiency decreases
Solution Approach 1:
By merging BCAAs with L-Alanine in a balanced composition, the patent achieves enhanced absorption efficiency that allows for effective muscle protein synthesis without the diminishing returns associated with high-dose BCAA supplementation alone. The combination creates a synergistic effect that improves overall amino acid uptake.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination of BCAAs with L-Alanine significantly increases plasma and muscle absorption of BCAAs, leading to improved muscle mass and function in pathological and age-related conditions.
Implementation Method 1
the combination with L-Alanine increases the plasma and muscle absorption of BCAAs
Data Source
AI summary
The present invention relates to compositions comprising branched-chain amino acids (BCAA) and the amino acid L-Alanine and their use in the prevention and/or treatment of muscle wasting associated to pathological or age-related conditions.